| abstract |
The present invention relates to novel controlled release galenical dosage forms containing the PDE 5 inhibitor vardenafil and / or pharmaceutically acceptable salts, hydrates, solvates and / or polymorphic forms thereof as active ingredient, as well as their preparation. The invention further relates to the use of these new pharmaceutical dosage forms as medicaments and their use for the preparation of medicaments for the treatment and / or prevention of diseases in humans and animals. |